BioElectronics' Temple University Diabetic Foot Ulcer Study Published in the International Wound Journal
(firmenpresse) - FREDERICK, MD -- (Marketwire) -- 09/27/11 -- BioElectronics Corporation (PINKSHEETS: BIEL) (OTCQB: BIEL), the maker of inexpensive, disposable drug-free topical pain and healing devices, today announced the publication of an article in the International Wound Journal that outlines the effective use of BioElectronics Corporation Pulsed Radio Frequency Energy (PRFE) therapy to successfully treat diabetic and venous stasis ulcers.
"We are very pleased to be able to present this data to the medical field as we believe that our technology could contribute significantly in helping patients suffering from chronic wounds," commented Ian Rawe, PhD, principal author of the article. "The cost of health continues to increase and the treatment of diabetic ulcers runs into the billions of dollars annually. With our innovative products we are able to positively impact, not only the suffering, but also the health care costs involved in the treatment of chronic wounds."
Arnon Horev, VP Sales and Marketing of BioElectronics, commented, "This study on chronic wounds clearly demonstrates something we have known for a very long time. Our technology changes the game for wound healing. Not only are our devices effective in speeding healing and reducing levels of pain, it is also wearable, which makes it a viable solution to alleviate chronic body aches and pains. We plan to use the data from this study to further enhance our international marketing and future applications with the US FDA."
The article, titled, "" can be viewed at: .
BioElectronics is an award winning medical device developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and swelling. For more information, please see .
Ben Fichter
BioElectronics, Inc.
(301) 874-4890
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.09.2011 - 13:54 Uhr
Sprache: Deutsch
News-ID 70182
Anzahl Zeichen: 0
contact information:
Town:
FREDERICK, MD
Kategorie:
Personal Care & Fitness
Diese Pressemitteilung wurde bisher 183 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioElectronics' Temple University Diabetic Foot Ulcer Study Published in the International Wound Journal"
steht unter der journalistisch-redaktionellen Verantwortung von
BioElectronics Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
